RxDoctor Payments Data

Marina Morcos, MD

Family Medicine · Wilson, NCNPI 1306400809

Payments from drug & device makers

$496in general payments, 2019–2025

Across 18 payments — averaging $27.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$153
  • AbbVie$98
  • Avadel CNS Pharmaceuticals, LLC$76
  • Viatris Specialty LLC$65
  • Abbott$42
  • Boehringer Ingelheim$18
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$63,765
Medicare patients
118
Services billed
1,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$133,214
JardianceEmpagliflozin103$96,894
MounjaroTirzepatide42$43,304
EliquisApixaban56$41,466
RybelsusSemaglutide23$34,759
TrulicityDulaglutide29$32,296
XareltoRivaroxaban17$23,552
JanuviaSitagliptin Phosphate21$16,795
Repatha SureclickEvolocumab19$14,657
LinzessLinaclotide11$13,804
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,825
FarxigaDapagliflozin Propanediol17$11,876
Tresiba Flextouch U-100Insulin Degludec22$11,231
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$4,544
Atorvastatin Calcium394$4,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$153$167,972136 claims
Boehringer IngelheimJardiance$18$96,894103 claims
AbbVieLinzess$98$13,80411 claims
GSKTrelegy Ellipta$15$12,82514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Wilson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →